Michael F. Egan

875 total citations
8 papers, 707 citations indexed

About

Michael F. Egan is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Michael F. Egan has authored 8 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Psychiatry and Mental health and 3 papers in Neurology. Recurrent topics in Michael F. Egan's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Schizophrenia research and treatment (4 papers). Michael F. Egan is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Schizophrenia research and treatment (4 papers). Michael F. Egan collaborates with scholars based in United States, Czechia and Japan. Michael F. Egan's co-authors include Daniel R. Weinberger, Terry E. Goldberg, James M. Gold, Thomas W. Weickert, Richard Jed Wyatt, Joel E. Kleinman, Thomas M. Hyde, Yasmin L. Hurd, Alessandro Bertolino and Daniel R. Weinberger and has published in prestigious journals such as American Journal of Psychiatry, Journal of Neurochemistry and The British Journal of Psychiatry.

In The Last Decade

Michael F. Egan

8 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael F. Egan United States 8 394 256 220 95 92 8 707
KF Berman United States 7 408 1.0× 423 1.7× 306 1.4× 114 1.2× 59 0.6× 11 794
Matthew T. Avila United States 16 289 0.7× 203 0.8× 152 0.7× 202 2.1× 43 0.5× 23 683
Shin’Ya Tayoshi Japan 14 288 0.7× 232 0.9× 229 1.0× 138 1.5× 24 0.3× 16 750
Jan Malát Canada 5 355 0.9× 210 0.8× 369 1.7× 164 1.7× 87 0.9× 14 725
C. Stephenson United Kingdom 11 239 0.6× 337 1.3× 161 0.7× 96 1.0× 41 0.4× 15 697
Ikiko Yamashita Japan 18 559 1.4× 494 1.9× 245 1.1× 128 1.3× 44 0.5× 20 998
Christopher H van Dyck United States 4 316 0.8× 226 0.9× 438 2.0× 164 1.7× 81 0.9× 6 749
Lisa D. Kochan United States 10 433 1.1× 364 1.4× 589 2.7× 346 3.6× 62 0.7× 11 1.1k
Jianguo Shi China 15 295 0.7× 178 0.7× 117 0.5× 185 1.9× 28 0.3× 30 715
Joel E. Kleinman United States 11 347 0.9× 101 0.4× 313 1.4× 254 2.7× 77 0.8× 13 743

Countries citing papers authored by Michael F. Egan

Since Specialization
Citations

This map shows the geographic impact of Michael F. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Egan more than expected).

Fields of papers citing papers by Michael F. Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Egan. The network helps show where Michael F. Egan may publish in the future.

Co-authorship network of co-authors of Michael F. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Egan. A scholar is included among the top collaborators of Michael F. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Egan. Michael F. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Weickert, Thomas W., et al.. (2000). Cognitive Impairments in Patients With Schizophrenia Displaying Preserved and Compromised Intellect. Archives of General Psychiatry. 57(9). 907–907. 433 indexed citations
2.
Callicott, Joseph H., et al.. (2000). Selective Relationship Between Prefrontal N-Acetylaspartate Measures and Negative Symptoms in Schizophrenia. American Journal of Psychiatry. 157(10). 1646–1651. 76 indexed citations
3.
Egan, Michael F., et al.. (1997). Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. The British Journal of Psychiatry. 171(6). 574–577. 42 indexed citations
4.
Egan, Michael F., Richard Jed Wyatt, Thomas M. Hyde, & Joel E. Kleinman. (1995). Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose. Psychopharmacology. 117(1). 74–81. 24 indexed citations
5.
Egan, Michael F., Yasmin L. Hurd, Thomas M. Hyde, et al.. (1994). Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic‐induced dyskinesias. Synapse. 18(3). 178–189. 76 indexed citations
6.
Egan, Michael F., et al.. (1994). Selective reduction in dopamine turnover in the rat frontal cortex and hypothalamus during withdrawal from repeated cocaine exposure. European Journal of Pharmacology. 254(1-2). 127–132. 15 indexed citations
7.
Karoum, Farouk, Stanisław J. Chrapusta, Michael F. Egan, & R J Wyatt. (1993). Absence of 6‐Hydroxydopamine in the Rat Brain After Treatment with Stimulants and Other Dopaminergic Agents: A Mass Fragmentographic Study. Journal of Neurochemistry. 61(4). 1369–1375. 31 indexed citations
8.
Chrapusta, Stanisław J., et al.. (1992). γ-Butyrolactone-sensitive and -insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions. European Journal of Pharmacology. 222(1). 129–135. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026